Vascularised vitreoretinopathy: The role of growth factors

Eye

Volumn 10, Issue 6, 1996, Pages 691-696

  Boulton, M E ^a,b   Foreman, D ^a   McLeod, D ^a  

^a Manchester Royal Eye Hospital ^*

^b MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR;

BLINDNESS; CONFERENCE PAPER; DIABETIC RETINOPATHY; HUMAN; LASER COAGULATION; PROTEIN LOCALIZATION; RETINA BLOOD FLOW; RETINA CAPILLARY; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; VISUAL IMPAIRMENT; VITREORETINOPATHY; VITREOUS BODY;

EID: 0030448301     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1996.162     Document Type: Conference Paper

References (49)

1. Boulton M, McLeod D, Garner A. Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects. Eye 1988;2(Suppl):S124-39.
2. Ashton N. Arteriolar involvement in diabetic retinopathy. Br J Ophthalmol 1953;37:282-92.
3. Ashton N. Studies of retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmol 1963;47:521-38.
4. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948;68:137-86.
5. Klagsbrun N, D'Amore P. Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-39.
6. Schultz GS, Grant M. Neovascular growth factors. Eye 1991;5:170-80.
7. Boulton M, Patel B, Khaliq A, Moriarty P, Jarvis-Evans J, McLeod D. Modulators and milieu in preretinal neovascularisation. Eye 1992;6:560-5.
8. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi B-Z. Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994;5:89-97.
9. Connolly D. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991;47:219-23.
10. Ferrara N, Houck K, Jakeman L, Winer J, Leung D. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991;47:211-8.
11. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995;164:385-94.
12. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularisation. Proc Natl Acad Sci USA 1995;92:905-9.
13. Heath JK. Growth factors. Oxford: IRL Press, 1993.
14. Wrana J, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β; receptor. Nature 1994;370:341-6.
15. Korhonen J, Partanen J, Eerola E, Vainikka S, Alitalo R, Makela T, Sandberg M, Hirvonen H, Alitalo K. Five FGF receptors with distinct expression patterns. In: Steiner R, Langer R, editors. Angiogenesis: key principles. Basel: Birkhauser, 1992: 91-100.
16. Grant M, Russell B, Fitzgerald C, Merimee T. Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularisation. Diabetes 1986;35:416-20.
17. Meyer-Schwickerath R, Pfeiffer A, Blum F, Freyberger H, Klein M, Losche C, Rollman R, Schatz H. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in non-diabetic and diabetic subjects. J Clin Invest 1993;92:2620-5.
18. Sivalingham A, Kenney J, Brown G, Benson W, Donoso L. Basic fibroblast growth factor levels in the vitreous with proliferative diabetic retinopathy. Arch Ophthalmol 1991;108:869-72.
19. Aiello L, Avery L, Arrigg P, Keyt B, Jampel H, Shah S, et al. Vascular endothelial cell growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordes. N Engl J Med 1994;331:1480-7.
20. Gregor Z, Moriarty P, Khaliq A, McLeod D, Boulton M. Growth factor levels in the diabetic vitreous: correlation with type of diabetes and neovascular activity. Invest Ophthalmol Vis Sci 1995;36:S441.
21. Waldbillig R, Jone E, Schoen T, Moshayedi P, Heidersbach S, Bitar M, van Kuijk F, de Juan E, Kador P, Chader G. Vitreal insulin like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics. Curr Eye Res 1994;13:539-46.
22. Shimasaki S, Ling N. Identification and molecular characterisation of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1992;3:243-66.
23. Hanneken A, Baird A. Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid. Invest Ophthalmol Vis Sci 1995; 36:1192-9.
24. Hanneken A, deJuan E, Lutty G, Fox G, Schiffer S, Hjelmand L. Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol 1991;109:1005-11.
25. Fredj-Reygrobellet D, Baudoin C, Negre F, Caruelle J, Gastaud P, Lapalus P. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 1991;23:154-61.
26. Patel B, Hiscott P, Charteris D, Mather J, McLeod D, Boulton M. Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Br J Ophthalmol 1994;78:714-8.
27. Robbins S, Mixon R, Wilson D, Hart C, Robertson J, Westra I, Planck S, Rosenbaum J. Platelet-derived growth factor ligands and receptors immunolocalised in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994;35:3649-63.
28. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994;112:1476-82.
29. Patz A. Clinical and experimental studies on retinal neovascularisation. Am J Ophthalmol 1982;94:715-43.
30. Weiter J, Zuckerman R. The influence of the photoreceptor-RPE complex on the inner retina: an explanation for the beneficial effects of photocoagulation. Ophthalmology 1980;87:1133-9.
31. McNaught E, Foulds W, Johnson N. The permeability of the posterior blood-retinal barrier after xenon coagulation: a study using fluorescein labelled dextrans. Br J Ophthalmol 1981;65:473-7.
32. Glaser B, Campochairo P, Davis J, Jerdan J. Retinal pigment epithelial cells release inhibitors of neovascularisation. Ophthalmology 1987;94:780-4.
33. Zhang N, Samadani E, Frank R. Mitogenesis and retinal pigment epithelial cell mitogen expression in the rat after krypton laser photocoagulation. Invest Ophthalmol Vis Sci 1993;34:2412-24.
34. Xiao M. A study of cellular responses to retinal laser photocoagulation in the miniature pig. PhD thesis, University of Manchester, 1995.
35. Lutty G, Ikeda K, Chandler C, McLeod D. Immunohistochemical localisation of transforming growth factor-β in human photoreceptors. Curr Eye Res 1991;10:61-74.
36. Ie D, Gordon L, Glaser B, Pena P. Transforming growth factor-beta2 levels increase following retinal laser photocoagulation. Curr Eye Res 1991;10:61-74.
37. Boulton M, Khaliq A, McLeod D, Moriarty P. Effect of hypoxia on the proliferation of microvascular cells in vitro. Exp Eye Res 1994;59:243-6.
38. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial cell growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
39. Shima D, Adamis A, Ferrara N, Yeo K, Yeo T, Allende D, Folkman J, D'Amore P. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterisation of vascular endothelial growth factor (VEGF) as the mitogen. Molecular Med 1995;1:182-93.
40. Khaliq A, Patel B, Jarvis-Evans J, Moriarty P, McLeod D, Boulton M. Oxygen modulates production of bFGF and TGF-β by retinal cells in vitro. Exp Eye Res 1995;60:415-24.
41. Khaliq A. The effect of oxygen on the production of, and response to growth factors by retinal cells in vitro: its relationship to the vasoproliferative retinopathies. PhD thesis, University of Manchester, 1994.
42. Miller J, Adamis A, Shima D, D'Amore P, Moulton R. et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145:574-84.
43. Pe'er J, Schweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascular diseases. Lab Invest 1995;72:615-8.
44. Aiello L, Pierce E, Foley E, Takagi H, Chen H, Riddle L, Ferrara N, King G, Smith L. Suppression of retinal neovascularisation in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457-61.
45. 3H]-thymidine uptake in venular and capillary endothelial cells in vivo. Invest Ophthalmol Vis Sci 1990;31:1238-44.
46. Lewis G, Erickson P, Guerin C, Anderson D, Fisher S. Basic fibroblast growth factor: a potential regulator of proliferation and intermediate expression in the retina. J Neurosci 1992;12:3968-78.
47. Grant M, Mames R, Fitzgerald C, Ellis E, Aboufriekha M, Guy J. Insulin-like growth factor-I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 1993;36:282-91.
48. 2 for the treatment of full-thickness macular holes. Ophthalmology 1992;99:1162-72.
49. Tolentino M, Miller J, Gragoudas E, Moulton R, Chazistefanou K, et al. Vascular endothelial growth factor is sufficient to produce ocular neovascularisation in a non-human primate. Invest Ophthalmol Vis Sci 1995;36:S402.